Amgen AMGN Stock
Amgen Price Chart
Amgen AMGN Financial and Trading Overview
Amgen stock price | 302.85 USD |
Previous Close | 222.28 USD |
Open | 223.01 USD |
Bid | 0 USD x 900 |
Ask | 0 USD x 800 |
Day's Range | 222.97 - 228.85 USD |
52 Week Range | 211.71 - 296.67 USD |
Volume | 2.63M USD |
Avg. Volume | 2.34M USD |
Market Cap | 122.06B USD |
Beta (5Y Monthly) | 0.642957 |
PE Ratio (TTM) | 15.529572 |
EPS (TTM) | 6.99 USD |
Forward Dividend & Yield | 8.52 (3.83%) |
Ex-Dividend Date | May 17, 2023 |
1y Target Est | 254.55 USD |
AMGN Valuation Measures
Enterprise Value | 148.8B USD |
Trailing P/E | 15.529572 |
Forward P/E | 12.125265 |
PEG Ratio (5 yr expected) | 7.25 |
Price/Sales (ttm) | 4.6606207 |
Price/Book (mrq) | 22.82346 |
Enterprise Value/Revenue | 5.682 |
Enterprise Value/EBITDA | 11.34 |
Trading Information
Amgen Stock Price History
Beta (5Y Monthly) | 0.642957 |
52-Week Change | -2.67% |
S&P500 52-Week Change | 20.43% |
52 Week High | 296.67 USD |
52 Week Low | 211.71 USD |
50-Day Moving Average | 232.81 USD |
200-Day Moving Average | 248.07 USD |
AMGN Share Statistics
Avg. Volume (3 month) | 2.34M USD |
Avg. Daily Volume (10-Days) | 2.42M USD |
Shares Outstanding | 534.33M |
Float | 533.2M |
Short Ratio | 3.21 |
% Held by Insiders | 0.21% |
% Held by Institutions | 79.82% |
Shares Short | 7.41M |
Short % of Float | 1.38% |
Short % of Shares Outstanding | 1.38% |
Dividends & Splits
Trailing Annual Dividend Rate | 7.95 |
Trailing Annual Dividend Yield | 3.57% |
5 Year Average Dividend Yield | 288.00% |
Payout Ratio | 0.5404 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 30.22% |
Operating Margin (ttm) | 36.83% |
Gross Margin | 74.93% |
EBITDA Margin | 50.10% |
Management Effectiveness
Return on Assets (ttm) | 8.15% |
Return on Equity (ttm) | 252.77% |
Income Statement
Revenue (ttm) | 26.19B USD |
Revenue Per Share (ttm) | 49 USD |
Quarterly Revenue Growth (yoy) | -2.10% |
Gross Profit (ttm) | 19.92B USD |
EBITDA | 13.12B USD |
Net Income Avi to Common (ttm) | 7.92B USD |
Diluted EPS (ttm) | 14.71 |
Quarterly Earnings Growth (yoy) | 92.50% |
Balance Sheet
Total Cash (mrq) | 31.56B USD |
Total Cash Per Share (mrq) | 59.07 USD |
Total Debt (mrq) | 61.6B USD |
Total Debt/Equity (mrq) | 1151.74 USD |
Current Ratio (mrq) | 3.145 |
Book Value Per Share (mrq) | 10.009 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.62B USD |
Levered Free Cash Flow (ttm) | 7.95B USD |
Profile of Amgen
Country | United States |
State | CA |
City | Thousand Oaks |
Address | One Amgen Center Drive |
ZIP | 91320-1799 |
Phone | 805 447 1000 |
Website | https://www.amgen.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 25200 |
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Q&A For Amgen Stock
What is a current AMGN stock price?
Amgen AMGN stock price today per share is 302.85 USD.
How to purchase Amgen stock?
You can buy AMGN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Amgen?
The stock symbol or ticker of Amgen is AMGN.
Which industry does the Amgen company belong to?
The Amgen industry is Drug Manufacturers-General.
How many shares does Amgen have in circulation?
The max supply of Amgen shares is 524.96M.
What is Amgen Price to Earnings Ratio (PE Ratio)?
Amgen PE Ratio is 42.39914300 now.
What was Amgen earnings per share over the trailing 12 months (TTM)?
Amgen EPS is 6.99 USD over the trailing 12 months.
Which sector does the Amgen company belong to?
The Amgen sector is Healthcare.
Amgen AMGN included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16920.58 USD — |
-0.58
|
6.33B USD — | 16873.97 USD — | 16989.6 USD — | — - | 6.33B USD — |
S&P 500 INDEX SPX | 5266.95 USD — |
-0.74
|
2.25B USD — | 5262.7 USD — | 5282.27 USD — | — - | 2.25B USD — |
S&P 500 (Yahoo.com) GSPC | 5266.95 USD — |
-0.74
|
2.21B USD — | 5262.7 USD — | 5282.27 USD — | — - | 2.21B USD — |
S&P 100 SP100 | 2529.54 USD — |
-0.54
|
943.47M USD — | 2523.35 USD — | 2537.24 USD — | — - | 943.47M USD — |
US100 NDX | 18736.75 USD — |
-0.7
|
740.92M USD — | 18706.63 USD — | 18814.81 USD — | — - | 740.92M USD — |
Dow Jones Industrial Average DJI | 38441.54 USD — |
-1.06
|
294.72M USD — | 38413.7 USD — | 38716.3 USD — | — - | 294.72M USD — |
Dow Jones U.S. Biotechnology In DJUSBT | 2757.65 USD — |
-1.11
|
86.37M USD — | 2746 USD — | 2775.01 USD — | — - | 86.37M USD — |
Nasdaq-100 ESG Net Notional Tot NDXESG24 | 1548.71 EUR 1692.95 USD |
-0.09
|
— — | 1541.97 EUR 1685.58 USD | 1555.23 EUR 1700.08 USD | — - | — — |
Nasdaq-100 Notional Net Return XNDXNNREUR | 3586.12 EUR 3920.12 USD |
-0.15
|
— — | 3573.16 EUR 3905.95 USD | 3600.94 EUR 3936.31 USD | — - | — — |
NASDAQ 100 Equal Weighted NDXE | 7334.66 USD — |
-1.08
|
— — | 7331.3 USD — | 7358.65 USD — | — - | — — |
NASDAQ 100 Total Return Index XNDX | 22521.51 USD — |
-0.7
|
— — | 22485.3 USD — | 22615.34 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
NASDAQ Biotechnology Total Retu XNBI | 4633.82 USD — |
-1.19
|
— — | 4606.47 USD — | 4646.26 USD — | — - | — — |
NASDAQ OMX CRD Global Sustainab QCRD | 1595.1 USD — |
0
|
— — | — — | — — | — - | — — |
Nasdaq US Low Volatility Divide LVDA | 1161.43 USD — |
-0.88
|
— — | 1160.89 USD — | 1165.79 USD — | — - | — — |
Nasdaq US Smart Pharmaceuticals NQSSPH | 1379.17 USD — |
-0.81
|
— — | 1374.72 USD — | 1383.25 USD — | — - | — — |
NASDAQ HealthCare IXHC | 967.78 USD — |
-1.12
|
— — | 964.91 USD — | 969.79 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 8246.62 USD — |
-0.57
|
— — | 8223.97 USD — | 8280.54 USD — | — - | — — |
NASDAQ 100 Pre Market Indicator QMI | 18689.17 USD — |
-0.96
|
— — | 18684.4 USD — | 18781.3 USD — | — - | — — |
NASDAQ Global Buyback Achievers DRBG | 2057.38 USD — |
-1.07
|
— — | 2055.41 USD — | 2079.84 USD — | — - | — — |
- {{ link.label }} {{link}}